###begin article-title 0
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
###end article-title 0
###begin p 1
###xml 27 47 27 47 <email xmlns:xlink="http://www.w3.org/1999/xlink">arao@idi.harvard.edu</email>
CORRESPONDENCE Anjana Rao: arao@idi.harvard.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 744 752 <span type="species:ncbi:405018">cardinal</span>
Activation of naive CD8+ T cells with antigen induces their differentiation into effector cytolytic T lymphocytes (CTLs). CTLs lyse infected or aberrant target cells by exocytosis of lytic granules containing the pore-forming protein perforin and a family of proteases termed granzymes. We show that effector CTL differentiation occurs in two sequential phases in vitro, characterized by early induction of T-bet and late induction of Eomesodermin (Eomes), T-box transcription factors that regulate the early and late phases of interferon (IFN) gamma expression, respectively. In addition, we demonstrate a critical role for the transcription factor Runx3 in CTL differentiation. Runx3 regulates Eomes expression as well as expression of three cardinal markers of the effector CTL program: IFN-gamma, perforin, and granzyme B. Our data point to the existence of an elaborate transcriptional network in which Runx3 initially induces and then cooperates with T-box transcription factors to regulate gene transcription in differentiating CTLs.
###end p 3
###begin p 4
F. Cruz-Guilloty and M.E. Pipkin contributed equally to this paper.
###end p 4
###begin p 5
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 274 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 276 277 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 407 408 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 410 411 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 495 496 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 584 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 586 587 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
Naive CD8+ T cells differentiate into effector CTLs with the ability to lyse antigen-bearing target cells by exocytosis of lytic granules containing perforin and granzymes, and to produce inflammatory cytokines such as IFN-gamma and TNF upon restimulation through the TCR (1, 2). In vivo experiments have elucidated many critical parameters governing the development and evolution of primary CTL responses (3, 4). In this study, we have used in vitro systems such as those developed to study CD4+ T cell differentiation to define the molecular basis of effector CTL differentiation (5, 6).
###end p 5
###begin p 6
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21</italic>
###xml 216 228 216 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eomesodermin</italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 330 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 539 540 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 778 779 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">Mice</span>
###xml 493 527 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
The T-box transcription factors Eomesodermin (Eomes) and T-bet are needed for important aspects of effector and memory CTL differentiation (7). In uninfected mice, compound deletion of the Tbx21 (encoding T-bet) and eomesodermin genes is associated with a selective loss of CD8+ T cells with an IL-2Rbeta-high, memory phenotype (8). Mice deficient for both T-bet and Eomes in T cells have impaired expression of cytolytic mediators, manifest poor cytolytic activity, and fail to control acute lymphocytic choriomeningitis virus infection (9). Nevertheless, the specific roles of T-bet and Eomes in clonal expansion and CTL differentiation have not yet been resolved: in particular, it is not known whether these transcription factors function redundantly to control effector CD8+ T cell differentiation, and whether they do so directly by targeting specific effector cytokine and cytolytic genes.
###end p 6
###begin p 7
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il4</italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 602 603 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
Runx proteins, a family of three DNA-binding transcription factors, control thymocyte differentiation and the CD4/CD8 lineage decision (10-13). Runx3 and perforin mRNA are expressed by double-positive (DP) thymocytes and CD8+ single-positive (SP) thymocytes but not in CD4+ SP cells (14). Although Runx3 is not expressed in naive CD4+ T cells, its expression is up-regulated during Th1 cell differentiation, and Runx3 influences Th1 cell differentiation and function through direct regulation of the Il4 and Ifng cytokine genes (15, 16). In contrast, all three Runx proteins are expressed in mature CD8+ T cells (10, 12), and Runx3-deficient CD8+ T cells show reduced cytolytic activity (12, 13). We therefore tested whether Runx3 influenced cytolytic T cell differentiation.
###end p 7
###begin p 8
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 404 408 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 615 619 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 624 628 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 760 764 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 859 863 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 868 872 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
In this report, we show that Runx3 and T-box factors synergistically regulate CTL differentiation and function. T-bet is induced quickly upon TCR stimulation and is required for early programming of cytokine production (17), whereas Eomes is induced later during differentiation and sustains IFN-gamma expression. Runx3 is required for Eomes and perforin expression, and both Eomes and Runx3 bind at the Prf1 locus; in contrast, perforin expression is unaffected in T-bet-deficient cells. T cells lacking Runx3 show decreased expression of IFN-gamma and granzyme B, and Runx3 also binds the promoter regions of the Ifng and Gzmb genes. Collectively, these results provide evidence for a complex transcriptional network in which Runx3 is a primary regulator of Gzmb expression but synergizes with T-bet and Eomes, respectively, to promote transcription of the Ifng and Prf1 genes.
###end p 8
###begin title 9
RESULTS AND DISCUSSION
###end title 9
###begin title 10
A cell culture system to monitor effector CTL differentiation
###end title 10
###begin p 11
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 373 388 <span type="species:ncbi:10090">transgenic mice</span>
We used a simple cell culture system to examine the kinetics of effector gene expression during CD8+ T cell differentiation. Naive CD8+ T cells from P14 TCR transgenic mice were activated for 2 d with anti-CD3 and anti-CD28 or with splenic APCs in the presence of Gp33 peptide, and were cultured in media containing 100 U/ml of recombinant human IL-2 (rhIL-2). We used TCR transgenic mice for these experiments because they provide a reliable source of CD8+ T cells that are truly naive; however, we chose not to stimulate cells with antigen in most experiments so as to avoid contamination with proteins and nucleic acids derived from APCs. There were only minor differences in gene expression during differentiation induced by antigen/APC versus anti-CD3/anti-CD28, and the major conclusions presented in this report are the same for both activating conditions.
###end p 11
###begin p 12
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Under our culture conditions, activated CD8+ T cells expanded exponentially and accumulated for >8 d. We limited our analysis to the first 6-8 d after activation, a period that coincides with clonal expansion of CD8+ T cells after activation in vivo.
###end p 12
###begin title 13
Distinct expression kinetics of perforin and granzyme B during CTL development in culture
###end title 13
###begin p 14
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 145 139 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 237 248 237 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;D</xref>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 465 476 465 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;D</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 654 669 654 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 756 764 756 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 951 959 947 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 970 978 966 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
Our experiments revealed clear differences in the kinetics of perforin, granzyme B, and cytokine expression during CD8+ T cell activation (Fig. 1). Naive T cells showed detectable expression of perforin mRNA as well as perforin protein (Fig. 1, A-D). Relative to its expression in naive T cells, perforin (Prf1) mRNA expression did not increase appreciably at day 2 but showed a reproducible decrease at day 4, followed by robust reexpression between days 4 and 8 (Fig. 1, A-D). In contrast, granzyme B (Gzmb) mRNA was low or undetectable in naive T cells but was strongly up-regulated by day 2 after stimulation and increased progressively until day 6 (Fig. 1, A and B); similarly, granzyme B protein was expressed by day 4 and remained high until day 6 (Fig. 1 E). As expected, a small fraction of naive T cells expressed the cytokines IFN-gamma and TNF in response to stimulation, and this capacity increased significantly in differentiated cells (Fig. 1 E; see also Fig. 2 A).
###end p 14
###begin p 15
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetics of gene expression during CD8<sup>+</sup> T cell differentiation.</bold>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes</italic>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 822 823 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 953 954 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Kinetics of gene expression during CD8+ T cell differentiation. (A) Kinetics of Prf1, Gzmb, Tbx21 (T-bet), and Eomes mRNA expression in differentiating P14 CD8+ T cells analyzed by Northern blotting. RNA from day 7 Th1 cells was used as a control. Sizes of mRNA transcripts are indicated. (B) Quantification of relative mRNA amounts by phosphorimager analysis. (C) Kinetics of protein expression in differentiating P14 CD8+ T cells analyzed by immunoblotting. Sizes of protein bands are indicated. (D) Relative protein amounts quantified from the Western blots. (E) Intracellular staining for granzyme B, IFN-gamma, and TNF. Granzyme B staining was specific relative to an isotype control (not depicted). Cells were restimulated with PMA and ionomycin for 4 h. (F) FACS-based assay to measure cytolytic activity of P14 CD8+ T cells against EL4 targets loaded with 0 (-) or 1 (+) muM Gp33 peptide (effector-to-target ratio = 5:1). Percentage of Annexin V+ (apoptotic) target cells in the CD8-negative EL4 target population (dot plots) was determined (histograms). Cytolytic activity was blocked by incubation with 2 mM EGTA (not depicted), confirming involvement of the granule exocytosis (perforin-granzyme B) pathway. Data are representative of at least five (A-E) or three (F) independent experiments.
###end p 15
###begin p 16
###xml 124 132 124 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 669 677 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 825 833 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
We evaluated antigen-dependent cytolytic function in a short-term assay in which target cell death was measured within 2 h (Fig. 1 F). By limiting the duration of TCR stimulation, this strategy minimizes cytolysis secondary to new gene expression during the period of the assay. Naive T cells did not display significant cytolytic function in this short-term assay (unpublished data), most likely because they express immature (unprocessed) forms of perforin and lack the capacity to degranulate (18, 19). Even after activation for 2 or 4 d, the cells showed poor cytolytic activity (Fig. 1 F), in striking contrast to their capacity for efficient cytokine production (Fig. 1 E). Only cells cultured until day 6 displayed robust cytotoxicity, as judged by their ability to induce apoptosis in a large number of target cells (Fig. 1 F).
###end p 16
###begin p 17
These results show that after a strong priming stimulus through TCRs and co-stimulatory receptors in vitro, granzyme B expression and the ability to produce effector cytokines are programmed early, whereas perforin expression and cytolytic function are induced later, during the phase of clonal expansion in IL-2. Therefore, the two major effector functions of CTL, cytokine production and cytolytic activity, are not intrinsically coregulated.
###end p 17
###begin title 18
Distinct kinetics of T-bet and Eomes expression during CTL differentiation
###end title 18
###begin p 19
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifn</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 304 315 304 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;D</xref>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 492 507 492 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and C</xref>
###xml 523 538 523 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and D</xref>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 734 749 734 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and C</xref>
###xml 833 848 833 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and C</xref>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 1056 1071 1044 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and D</xref>
The T-box transcription factors T-bet and Eomes have been linked to the regulation of genes encoding effector cytokines (e.g., Ifng) and genes important for cytolytic function (e.g., Prf1 and GzmB) (20). We investigated the kinetics of expression of these transcription factors in our in vitro cultures (Fig. 1, A-D). T-bet mRNA and protein were not detectable in naive CD8+ T cells, but were strongly induced upon TCR priming (day 2) and remained expressed through day 6 of differentiation (Fig. 1, A and C; quantified in Fig. 1, B and D). In contrast, Eomes expression was low or undetectable at both the mRNA and protein levels in naive CD8+ T cells, and TCR priming in culture had only a modest effect on its expression at day 2 (Fig. 1, A and C). Strong induction of Eomes mRNA and protein was only observed at day 4 and later (Fig. 1, A and C). T-bet mRNA expression slightly preceded the expression of GzmB mRNA; similarly, Eomes mRNA and protein were expressed approximately1 d ahead of the reexpression of perforin mRNA and protein, respectively (Fig. 1, B and D).
###end p 19
###begin p 20
###xml 488 490 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
This detailed kinetic analysis suggested that, under our culture conditions, T-bet and Eomes contribute to distinct aspects of gene transcription during CTL differentiation. T-bet is required early for IFN-gamma production, and our data suggested that Eomes might not function during this early period but rather might contribute later to the control of perforin expression. Our data seemed most consistent with a model in which TCR signals induce T-bet, which in turn induces IFN-gamma (17) and possibly granzyme B; subsequently, Eomes is induced during the period of clonal expansion in IL-2 and activates perforin expression.
###end p 20
###begin title 21
Perforin and granzyme B expression are not appreciably regulated by T-bet
###end title 21
###begin p 22
###xml 135 136 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 162 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21</italic>
###xml 200 202 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 204 206 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 220 223 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 215 223 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>&#8722;/&#8722;</sup></italic>
###xml 227 228 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 280 288 272 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 384 385 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 463 471 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 573 579 565 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 682 690 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 763 767 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 801 809 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 912 920 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
To test the model outlined in the previous paragraph directly, we compared the expression of IFN-gamma, perforin, and granzyme B in CD8+ T cells from WT and Tbx21 (T-bet)-deficient mice. As expected (17, 21), naive Tbx21-/- CD8+ T cells produced IFN-gamma poorly upon activation (Fig. 2 A). Notably, this deleterious effect of T-bet deficiency was only observed in differentiating CD8+ T cells until day 4 of culture but was almost completely mitigated by day 6 (Fig. 2 A). This most likely reflected compensation by Eomes, which was strongly induced between days 4 and 6 (Fig. 1). In contrast, T-bet-deficient T cells cultured for 6 d showed no defect in perforin mRNA expression (Fig. 2 B, compare lanes 1 and 4). We consistently observed a modest reduction in GzmB mRNA in T-bet-deficient T cells (Fig. 2 B, compare lanes 1 and 4), which did not translate into a decrease in expression of granzyme B protein (Fig. 2 C).
###end p 22
###begin p 23
###xml 0 104 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Regulation of perforin, granzyme B, and IFN-&#947; expression by T-bet and Eomes in differentiating CTLs.</bold>
###xml 142 145 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 137 145 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>+/+</sup></italic>
###xml 173 176 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 168 176 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>&#8722;/&#8722;</sup></italic>
###xml 196 197 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 408 409 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 451 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 456 460 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 505 506 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 823 824 795 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 895 898 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 890 898 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>+/+</sup></italic>
###xml 908 911 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 903 911 871 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>&#8722;/&#8722;</sup></italic>
###xml 1179 1180 1143 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1190 1191 1150 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Regulation of perforin, granzyme B, and IFN-gamma expression by T-bet and Eomes in differentiating CTLs. (A) IFN-gamma expression by WT (Tbx21+/+) and T-bet-deficient (Tbx21-/-) T cells. Naive CD8+ T cells, or cells activated and cultured for 4 or 6 d, were restimulated with PMA and ionomycin for 6 h, and IFN-gamma expression was assessed by intracellular staining. Numbers show the percentage of IFN-gamma+ cells. (B) Northern blot analysis of Prf1 and GzmB mRNA expression in WT or T-bet-deficient CD8+ T cells activated and either left uninfected (uninf) or transduced with retroviruses expressing Eomes-VP16 (Eo-VP16) or an empty IRES-GFP cassette (GFP). Total cellular RNA was analyzed on day 6 of culture. The frequency of transduced cells in the cultures was equivalent for both constructs (approximately65-70% GFP+ cells; not depicted). (C) Granzyme B and IFN-gamma expression by Tbx21+/+ and Tbx21-/- T cells analyzed in restimulated cells that had been cultured for 5 d. (D) IFN-gamma production by cells transduced with Eo-VP16 or control (GFP) retroviruses (RV) measured on day 4 after 6 h of restimulation with PMA and ionomycin. Numbers show the percentage of GFP+ IFN-gamma+ cells. Results are representative of three (A and C) or two (B and D) independent experiments.
###end p 23
###begin p 24
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>&#8722;/&#8722;</sup></italic>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 414 415 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 564 565 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 575 583 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 618 622 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 716 720 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GzmB</italic>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
To examine the role of Eomes, we transduced naive CD8+ T cells from WT and Tbx21-/- mice with retroviruses containing internal ribosome entry site (IRES)-GFP that were either empty or encoded a strongly transactivating version of Eomes (Eo-VP16) (8), and expanded them for 6 d under our culture conditions. Eo-VP16, but not the empty GFP retrovirus, increased perforin expression in both WT and T-bet-deficient CD8+ T cells (Fig. 2 B, lanes 2, 3, 5, and 6). As expected, Eo-VP16 also rescued the early defect in IFN-gamma production observed in T-bet-deficient CD8+ T cells (Fig. 2 D). However, Eo-VP16 did not induce GzmB mRNA expression in either WT or T-bet-deficient cells; thus, the partial T-bet dependence of GzmB mRNA expression cannot be compensated for by Eo-VP16.
###end p 24
###begin title 25
Runx3 controls multiple aspects of the CTL differentiation program, in part through induction of Eomes
###end title 25
###begin p 26
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 245 248 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3</italic>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 589 579 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 693 696 689 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 688 696 684 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 726 741 722 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and B</xref>
###xml 749 752 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 744 752 740 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 848 856 844 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 955 956 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 988 996 980 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
Because Runx3 is highly expressed in peripheral CD8+ T cells, and because of the T-bet-Runx3 cooperation we observed earlier in CD4+ T cells (15), we examined the role of Runx3 in effector CTL differentiation. We isolated CD8+ T cells from Runx3-/- (KO) mice of the outbred ICR background and their WT Runx3+/+ littermates by positive selection with anti-CD8 magnetic beads (Figs. S1 and S2, available at ). Strikingly, Runx3-/- CD8+ T cells were strongly impaired in their ability to differentiate into effector CTLs, as judged by expression of perforin, granzyme B, and IFN-gamma (Fig. 3). Compared with WT T cells, perforin mRNA and protein expression were essentially undetectable in Runx3-/- T cells at day 6 of culture (Fig. 3, A and B). Runx3-/- T cells also had no detectable Eomes expression; in contrast, T-bet expression was unimpaired (Fig. 3 A). Furthermore, Runx3 was required for maximal production of IFN-gamma, but not TNF or IL-2, by CD8+ T cells restimulated at day 6 (Fig. 3 C).
###end p 26
###begin p 27
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Key role for Runx3 in effector CTL differentiation.</bold>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>+/+</sup></italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 261 265 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 290 293 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 285 293 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>+/+</sup></italic>
###xml 306 309 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 301 309 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 313 314 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 485 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 477 485 467 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>+/+</sup></italic>
###xml 498 501 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 501 483 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 505 506 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 604 605 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 745 749 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 989 990 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1076 1080 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
Key role for Runx3 in effector CTL differentiation. (A) Western analysis of Runx3, Eomes, T-bet, and perforin expression in Runx3+/+ versus Runx3-/- CD8+ SP T cells differentiated for 6 d. beta-Actin was used as a loading control. (B) Northern blot analysis of Prf1 mRNA expression in Runx3+/+ versus Runx3-/- CD8+ T cells differentiated for 6 d. beta-Actin was used as a loading control. (C) Expression of granzyme B, IFN-gamma, TNF, and IL-2 by resting or restimulated (6 h) Runx3+/+ versus Runx3-/- CD8+ SP T cells differentiated for 6 d. The vertical gray line indicates the granzyme B MFI for WT GFP+ cells. Results in A-C are representative of two independent experiments. (D) ChIP analysis of binding of endogenous Runx3 and Eomes to the Prf1 locus. Enrichment of the indicated genomic regions was evaluated by real-time PCR of DNA from immunoprecipitated and input chromatin. The data are the means of duplicate measurements from two chromatin preparations from two independent CD8+ T cell differentiations. The efficiency of recovery of input for the -1-kb region of Prf1 was 0.97% for the Runx3 ChIP and 0.5% for the Eomes ChIP.
###end p 27
###begin p 28
###xml 289 291 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 293 295 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 356 364 352 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 445 451 441 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 590 605 582 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B and D</xref>
We previously reported that Th1 cell differentiation was regulated through a feed-forward loop in which T-bet is up-regulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-gamma and silence IL-4, thus promoting stable differentiation toward the Th1 lineage (15, 22). Because (a) Runx3 appeared necessary for Eomes induction (Fig. 3 A), (b) the kinetics of Eomes expression paralleled those of perforin expression (Fig. 2), and (c) overexpression of Eo-VP16 in either WT or T-bet-deficient T cells led to an increase in both perforin and IFN-gamma expression (Fig. 2, B and D), we asked whether CTL differentiation was also potentially regulated by a feed-forward loop involving these same two classes of Runx and T-box transcription factors. Specifically, we asked whether Runx3, which was necessary for Eomes induction, then cooperated with Eomes to regulate transcription of the effector CTL markers perforin, IFN-gamma, and granzyme B.
###end p 28
###begin p 29
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 623 631 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il2rb</italic>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 886 890 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ifng</italic>
###xml 948 949 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 959 967 959 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
To test this hypothesis, we used chromatin immunoprecipitation (ChIP) assays to ask whether Eomes and Runx3 bound regulatory regions of the Prf1, Ifng, and Gzmb genes (Fig. 3 D). Both proteins associated with gene regulatory regions in differentiated CTLs. Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near -1 kb of the Prf1 gene (23); to the distal CTL-specific DNase I hypersensitive site 9 in the Prf1 locus (24); to the Ifng promoter near the TSS, as previously reported for Th1 cells (10); and to several DNase I hypersensitive sites in the Ifng locus (Fig. 3 D and not depicted) (25). Eomes bound primarily to the Prf1 TSS and the -1 kb enhancer; this binding was substantially greater than that observed at the promoter of the Il2rb gene, a known direct target of Eomes (8), and comparable to that observed at the Ifng TSS, a known target of T-box proteins in both Th1 and CD8+ T cells (Fig. 3 D) (17).
###end p 29
###begin p 30
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 172 180 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 223 224 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 375 383 375 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 488 496 488 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 500 501 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 598 613 594 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A and B</xref>
###xml 634 637 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 629 637 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 883 886 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 878 886 874 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 986 1001 978 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A and B</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
To determine whether Runx3 controlled the expression of CTL effector genes through its induction of Eomes, we retrovirally expressed Runx3 and Eo-VP16 in CD8+ T cells from Runx3-/- mice. Because of the limited number of CD8+ T cells in these mice, and because we saw no difference between Runx3-/- CD8+CD4- SP and CD8+CD4+ DP cells in our previous experiments, we used total Runx3-/- CD8+ T cells without further fractionation as recipients for retroviral transduction. Reconstitution of Runx3-/- CD8+ T cells with Runx3 restored expression of Eomes as well as perforin, granzyme B, and IFN-gamma (Fig. 4, A and B). In addition, Runx3-/- T cells showed a compensatory up-regulation of Runx1, which was suppressed upon reconstitution with Runx3, indicating that Runx1 is a target of repression by Runx3. Notably, Eo-VP16 did not up-regulate perforin expression when expressed in Runx3-/- cells, even though it restored the capacity to induce IFN-gamma expression upon TCR restimulation (Fig. 4, A and B). This result suggests strongly that perforin expression requires Runx3 and Eomes.
###end p 30
###begin p 31
###xml 0 86 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Runx3 controls Eomes, perforin, granzyme B, and IFN-&#947; expression in effector CTLs.</bold>
###xml 91 94 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 86 94 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>+/+</sup></italic>
###xml 103 106 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 98 106 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 110 111 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 377 378 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1054 1055 1034 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1329 1330 1305 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1644 1648 1612 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
Runx3 controls Eomes, perforin, granzyme B, and IFN-gamma expression in effector CTLs.Runx3+/+ or Runx3-/- CD8+ T cells were activated and transduced with retroviruses bearing an empty IRES-GFP cassette (GFP) or also encoding Eomes-VP16 (Eo-VP16) or Myc-Runx3 (Runx3). The frequency of transduced cells in the cultures was equivalent for all constructs (approximately75-90% GFP+ cells; not depicted). (A) Protein expression in whole-cell extracts (day 6) was analyzed by immunoblotting. Overexpression of Eomes-VP16 cannot be detected with the Eomes antibody, as the C-terminal epitope is within the region that has been replaced with the VP16 transactivation domain. (B) Expression of granzyme B and IFN-gamma after culture for 6 d and restimulation for 4 h with PMA and ionomycin was determined by intracellular staining. The percentage of positively stained cells is shown above the gate; the mean fluorescence intensity (MFI) of granzyme B staining for the total population is shown below the gate. The vertical gray lines indicate the MFI for WT GFP+ cells. Results are representative of at least two independent experiments. (C) Schematic diagram of the transcriptional network involving Runx3 and T-box factors. T-bet is induced by TCR signals and is essential for early IFN-gamma expression. Runx3 is present in naive CD8+ T cells and represses Runx1 and induces Eomes, perforin, granzyme B, and IFN-gamma expression. Eomes may participate in sustaining late IFN-gamma expression, whereas Runx3 and Eomes (but not T-bet) may cooperate to activate perforin expression. The dotted line indicates the partial effect of T-bet deficiency on Gzmb mRNA but not granzyme B protein expression.
###end p 31
###begin p 32
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 352 355 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 347 355 347 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 519 527 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
As expected from their defect in perforin and granzyme B expression, Runx3-/- CD8+ T cells showed defective cytolytic activity in a mixed lymphocyte reaction (12). However, TCR-stimulated Runx3-/- CD8+ cells were as effective as WT cells in killing tumor cells in a redirected CTL assay (12). Furthermore, CD8+ cells from the peritoneal cavity of Runx3-/- mice immunized with certain tumor cells effectively killed these targets (13). Therefore, although activation of the perforin/granzyme B machinery is defective in Runx3-/- CD8+ cells, these cells are not entirely devoid of cytolytic activity and could still effectively kill targets, possibly by alternative mechanisms such as the Fas-Fas ligand pathway.
###end p 32
###begin title 33
Runx3 and T-box factors control a complex program of transcriptional regulation during CTL differentiation
###end title 33
###begin p 34
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 535 540 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eomes</italic>
###xml 545 550 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
Collectively, these data provide evidence that Runx3, together with T-box factors, orchestrates a complex program of transcriptional regulation in differentiating CTL (Fig. 4 C). Runx3 is present in naive CD8+ T cells before activation (12). It represses Runx1 and has a positive role in the induction of Eomes, granzyme B, perforin, and IFN-gamma. Runx3 binds to promoters and putative regulatory regions of the latter three genes, suggesting a direct effect on gene expression. Additional experiments are needed to determine whether Eomes and Runx1 are also direct target genes of Runx3.
###end p 34
###begin p 35
###xml 169 177 165 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 252 255 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 247 255 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 263 271 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 411 419 403 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
Surprisingly, Runx3 contributed to the optimal expression of TNF, IL-2, and IFN-gamma at day 4 (Fig. S2). For TNF and IL-2, the requirement for Runx3 subsides by day 6 (Fig. 3 C), possibly because of compensation by Runx1, which is derepressed in Runx3-/- cells (Fig. 4 A). Runx3 continues to be required for IFN-gamma expression even at day 6, perhaps because of its role in the induction of Eomes expression (Fig. 4 A).
###end p 35
###begin p 36
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 593 594 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 673 674 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 676 678 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 759 760 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
An unexpected finding was that the two T-box transcription factors, T-bet and Eomes, are up-regulated with very different kinetics in CD8+ T cells under our culture conditions and have nonredundant roles in the subsequent expression of key effector proteins (Fig. 4 C). T-bet is needed early to confer on activated CD8+ T cells the competence to produce IFN-gamma upon restimulation, but its function is less important at later times. Eomes, which is induced late and functions downstream of Runx3, may substitute for T-bet in promoting the acute expression of IFN-gamma in restimulated CTLs (8). Indeed, T-bet and Eomes both contribute to perforin expression in NK cells (8, 26), and Eomes induces granzyme B as effectively as T-bet in developing Th2 cells (7); thus, the relative roles of these T-box transcription factors vary depending on cell type.
###end p 36
###begin p 37
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 138 146 138 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gzmb</italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prf1</italic>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 519 527 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T-bet<sup>&#8722;/&#8722;</sup></italic>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 531 539 531 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 813 814 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
Surprisingly, however, Eomes and T-bet appeared nonredundant in their ability to induce two other markers of CTL function, Prf1 and Gzmb (Fig. 4 C). Rather, T-bet and Eomes were involved in regulating granzyme B and perforin expression, respectively: up-regulation of T-bet and Eomes mRNA and protein closely preceded up-regulation of Gzmb and Prf1 mRNA and protein, respectively. T-bet had no role in perforin expression under our culture conditions, and Eo-VP16 did not affect granzyme B expression when expressed in T-bet-/- or Runx3-/- cells. Because conventional Eomes-deficient mice die before precursor cells can be isolated for bone marrow transfers (27) and because T cells conditionally deficient in Eomes have only recently been described (9), we were unable to introduce Runx3 into Eomes-deficient CD8+ T cells to test formally whether Eomes cooperated with Runx3 to induce perforin expression.
###end p 37
###begin p 38
###xml 231 239 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 348 349 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 367 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 507 509 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 542 543 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Collectively, our data are consistent with a transcriptional network in which preexisting Runx3 cooperates with the induced T-box factors T-bet and Eomes and IL-2Rbeta signals (unpublished data) to orchestrate CTL differentiation (Fig. 4 C). Our data recall the "feed-forward" interaction between T-bet and Runx3 that we previously described in CD4+ (Th1) T cells (15) but are distinct in two respects: in differentiating Th1 cells, T-bet is induced by TCR signals and IFN-gamma, and in turn induces Runx3 (15), whereas in differentiating CD8+ T cells, preexisting Runx3 is required to induce the T-box transcription factor Eomes. Whole-genome experiments in these and other systems will be required to establish whether cooperation between T-box and Runx family transcription factors is a general feature of cellular differentiation programs.
###end p 38
###begin title 39
MATERIALS AND METHODS
###end title 39
###begin title 40
Antibodies and reagents.
###end title 40
###begin p 41
The following antibodies used for intracellular or surface stains were obtained from eBioscience: anti-IL-2, anti-IFN-gamma, anti-TNF, anti-granzyme B, anti-CD8, anti-CD25, and anti-CD44. Anti-CD69 was purchased from BD. For ChIP experiments, the anti-Eomes antibody was obtained from Abcam and the anti-Runx3 antibody was produced by the Groner laboratory. The following antibodies were used for immunoblotting: antiperforin (Abcam), anti-Eomes (Abcam), and anti-Pol-II (Santa Cruz Biotechnology, Inc.). The T-bet antibody was provided by L. Glimcher (Harvard School of Public Health, Boston, MA).
###end p 41
###begin p 42
The following reagents were used for the experiments presented in this report: Annexin V-FITC Apoptosis Detection Kit (BD), CD8 Negative Isolation Kit (Invitrogen), CD8 MicroBeads (Miltenyi Biotec), and SYBR Green PCR Core Reagents (Applied Biosystems). The Gp33 peptide (KAVYNFATC) was synthesized by the Tufts University Core Facility, and 10 mM of stock solutions was prepared in DMSO.
###end p 42
###begin title 43
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Isolation and culture of primary CD8+ T cells.
###end title 43
###begin p 44
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tcra<sup>&#8722;/&#8722;</sup></italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tbx21<sup>&#8722;/&#8722;</sup></italic>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 246 254 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 572 573 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 601 602 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 867 868 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 984 985 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:9925">goat</span>
CD8+ T cells from 4-8-wk-old Tcra-/- x P14 TCR transgenic (Taconic), C57BL/6J WT, or Tbx21-/- (The Jackson Laboratory) mice were purified (>95% purity) by negative selection (Invitrogen) from pooled spleen and lymph node cells. CD8+ T cells from Runx3-/- mice on the ICR background were purified by positive selection (Miltenyi Biotec). All mice were maintained in specific pathogen-free barrier facilities and used according to protocols approved by the Immune Disease Institute and the Harvard Medical School Animal Care and Use Committees. For stimulation, purified CD8+ T cells were cultured at 106 cells/ml (10 ml) in T25 flasks coated with 1 mug/ml each of anti-CD3 (clone 2C11) and anti-CD28 (clone 37.51) by pretreatment with 300 mug/ml goat anti-hamster IgG. After 48 h, cells were removed from the TCR stimulation and recultured at a concentration of 5 x 105 cells/ml in media supplemented with 100 U/ml rhIL-2. Every 24 h, viable cells were counted and readjusted to 5 x 105 cells/ml with fresh media containing the corresponding amount of rhIL-2.
###end p 44
###begin title 45
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Isolation of CD8+ T cells from Runx3-/- mice.
###end title 45
###begin p 46
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 394 395 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 634 626 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 740 743 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 735 743 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 930 933 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 937 938 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1476 1479 1476 1479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1471 1479 1471 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 1483 1484 1483 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1644 1651 1644 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 1656 1657 1656 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
Runx3-deficient T cells fail to silence CD4 expression normally (Fig. S1) (12, 13). We therefore further fractionated the positively selected CD8+ T cells from Runx3 KO mice into CD8+CD4- SP or CD8+CD4+ DP cells by separation using anti-CD4 magnetic beads. This yielded a Runx3 KO SP "enriched" population that contained 75% CD8+CD4- cells and a KO DP enriched population that contained 85% CD8+CD4+ cells (Fig. S1). The cells were stimulated with anti-CD3+ anti-CD28 for 2 d before removing them from the TCR stimulus and culturing them in media containing 100 U/ml IL-2. As previously reported, TCR-induced proliferation of Runx3-/- CD8+ T cells was severely impaired, irrespective of CD4 expression (Fig. S1) (12, 13). However, the Runx3-/- cells showed cell-surface expression patterns indicative of activated cells, including up-regulation of CD25 and CD69 (Fig. S1). As expected from their ability to up-regulate CD25, Runx3-/- CD8+ T cells responded to IL-2 supplementation after day 2 and efficiently expanded until day 6 of the culture period, albeit at slower rates compared with WT cells (Fig. S1). Although a fraction of the KO DP cells silenced CD4 expression after activation, the ratio of SP/DP cells in each enriched population remained constant thereafter, and we did not observe any major differences between these two populations throughout the culture period, indicating that in terms of effector CTL differentiation and under our culture conditions, Runx3-/- CD8+ T cells that also coexpress CD4 are indistinguishable from those that do not. The data presented in Fig. S2 are from Runx3 KO SP cells, whereas those shown in Figs. 3 and 4 are from total Runx3 KO CD8 cells.
###end p 46
###begin title 47
FACS-based cytotoxicity assay.
###end title 47
###begin p 48
###xml 137 138 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 487 488 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
To measure cytotoxicity, EL4 thymoma target cells were loaded with 0 or 1 muM Gp33 peptide for 2 h before a 2-h coincubation with P14 CD8+ T cells at the effector-to-target ratios indicated in the figures in 96-well round-bottom plates. After the coincubation period, cells were stained with Annexin V-FITC and anti-CD8-allophycocyanin. Data analysis was performed with FlowJo software (Tree Star, Inc.); EL4 target cells (CD8-negative events) were gated, and the percentage of Annexin V+ target cells was determined.
###end p 48
###begin title 49
Cytokine and surface marker staining.
###end title 49
###begin p 50
###xml 215 217 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
To assess cytokine production, cells were restimulated with 10 nM PMA + 1 muM ionomycin for 6 h (unless indicated otherwise in the figures), and intracellular cytokine stains were performed as previously described (28). To detect expression of surface molecules, cells were washed in PBS, resuspended in FACS wash buffer (3% FBS, 0.1% sodium azide, 30 mM Hepes, 1x PBS) containing the antibodies indicated in the figures at previously optimized concentrations, incubated for 15 min at room temperature (RT), washed, and resuspended in 2% formaldehyde fixative solution before acquisition on a FACSCalibur (BD).
###end p 50
###begin title 51
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Retroviral transduction of primary CD8+ T cells.
###end title 51
###begin p 52
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 232 233 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 237 238 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 452 453 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 669 670 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
For transduction experiments, viral supernatants were generated by calcium phosphate transfection of Phoenix cells and concentration by overnight centrifugation at 6,000 g. At approximately42 h after the initial TCR activation of 106 CD8+ T cells per well in 12-well plates, the culture media was removed and replaced with complete media supplemented with 8 mug/ml polybrene containing fresh plus concentrated virus. The plates were centrifuged at 700 g for 1 h at RT before returning to 37degreesC for an additional 5 h. Retroviral constructs for Eomes-VP16 and the MIG control empty vector were a gift from S.L. Reiner (University of Pennsylvania, Philadelphia, PA) (8).
###end p 52
###begin title 53
ChIP and real-time PCR analysis.
###end title 53
###begin p 54
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1001 1002 1001 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1532 1533 1525 1526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
20 x 106 CD8+ T cells per immunoprecipitation were fixed by adding a 1/10th volume of fixation solution (11.1% formaldehyde, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 50 mM Hepes) to 1 volume of culture media and were incubated for 10 or 30 min at RT. Fixation was stopped with 120 mM glycine on ice for 5 min. Fixed cells were washed 2x with cold PBS, 1x with cold solution I (10 mM Tris [pH 7.5], 10 mM EDTA, 0.5 mM EGTA, 1% Triton X-100), and 1x with cold solution II (10 mM Tris [pH 7.5], 1 mM EDTA, 0.5 mM EGTA, 200 mM NaCl). After washes, cell pellets were resuspended at 40 x 106 cells/ml in ChIP lysis buffer (150 mM NaCl, 25 mM Tris [pH 7.5], 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate plus protease and phosphatase inhibitors), and chromatin was sheared with a sonicator to yield 0.5-1-kb DNA fragments. After preclearing the sheared chromatin with protein A-sepharose beads and removing 5% as input chromatin, immunoprecipitation was performed by adding optimized antibody amounts (per 20 x 106 cell equivalents: 2.5 mug anti-Eomes, 1:100 dilution anti-Runx3), followed by overnight incubation at 4degreesC; protein A-sepharose beads were added for the last 3 h of the incubation period. Beads were washed 2x with RIPA buffer (50 mM Tris [pH 8], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% deoxycholate), 1x with high salt buffer (50 mM Tris [pH 8], 500 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS), and 1x with TE buffer. After the last wash, DNA was eluted by resuspending the beads in elution buffer (1% SDS, 100 mM NaHCO3). Both input and ChIP chromatin were then treated with RNase A (5 mug total) for 1 h at 37degreesC, followed by the addition of proteinase K (100 mug total) and overnight incubation at 65degreesC to reverse cross-linking. DNA was then purified with QIAquick columns (Gel Extraction Kit; QIAGEN) according to the manufacturer's instructions and resuspended in a 50-mul volume. For real-time PCR detection of immunoprecipitated targets using the SYBR Green PCR Kit, a standard curve was obtained with serial dilutions of input DNA for each sample, and 1 mul ChIP DNA was used per PCR reaction (performed in duplicates). Melt curves and agarose gels were analyzed to ensure amplification of specific target sequences. Refer to Table S1 (available at ) for a list of primer sets. The data are presented as the number of immunoprecipitated target sequences relative to input chromatin, assuming two copies of target sequence per cell equivalent used for the ChIP.
###end p 54
###begin title 55
Northern and Western blot analyses.
###end title 55
###begin p 56
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 198 199 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 356 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
RNA isolation and Northern blot analysis was performed as previously described (29). In brief, 10 mug of total RNA was loaded per lane and transferred to positively charged nylon membranes (Hybond-N+; GE Healthcare), which was confirmed by ethidium bromide staining of ribosomal RNA species on the membrane. Membranes were hybridized with 1 ng/ml alpha-[32P]dCTP-labeled trichloroacetic acid precipitable probe in ExpressHyb hybridization buffer (Clontech Laboratories, Inc.). All cDNA probes were confirmed to have the appropriate single-copy specificity under these conditions using genomic Southern blot analysis. Band intensities were acquired by phosphorimaging analysis.
###end p 56
###begin p 57
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 294 295 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
For Western analysis, whole-cell protein lysates were obtained from CD8+ T cells at the time points indicated in the figures during clonal expansion in 100 U/ml IL-2 with lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 10% glycerol, 5 mM EDTA, 1% NP-40) by resuspending samples in 10 mul per 106 cells and incubating on ice for 30 min in the presence of protease inhibitors. Immunoblot analysis was performed with the antibodies indicated in the figures after SDS-PAGE (10-30 mug of total protein was loaded per well). Quantification of detected protein was performed with an Intelligent Dark Box unit (LAS-3000; Fujifilm) and normalized for loading with the amount of RNA Pol-II detected in each lane.
###end p 57
###begin title 58
Online supplemental material.
###end title 58
###begin p 59
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3<sup>&#8722;/&#8722;</sup></italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows the characterization of peripheral CD8+ T cells from Runx3-/- mice. Fig. S2 shows effector protein expression by Runx3 WT and KO cells at day 4 of in vitro culture. Primer sequences used for ChIP experiments are shown in Table S1. Online supplemental material is available at .
###end p 59
###begin title 60
Supplementary Material
###end title 60
###begin title 61
[Supplemental Material Index]
###end title 61
###begin p 62
We thank S. Reiner for providing the Eomes-VP16 expression plasmid and members of the Rao laboratory for helpful discussions.
###end p 62
###begin p 63
This work was supported by National Institutes of Health grants CA42471 and AI44432 to A. Rao, and Israel Science Foundation grants to Y. Groner. M.E. Pipkin is supported by National Cancer Institute postdoctoral fellowship F32 CA126247-01. F. Cruz-Guilloty was supported by a Ford Foundation Predoctoral Fellowship. I.M. Djuretic and F. Cruz-Guilloty are both predoctoral fellows of the Ryan Foundation.
###end p 63
###begin p 64
The authors have no conflicting financial interests.
###end p 64

